Regeneron Ireland Designated Activity Company (DAC)
3 products tracked · names used in filings: Regeneron Ireland Designated Activity Company (DAC)
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Lynozyfic linvoseltamab | Authorised | 2025-04-23 |
| 🇪🇺 | Ordspono odronextamab | Authorised | 2024-08-22 |
| 🇪🇺 | Libtayo cemiplimab | Authorised | 2019-06-28 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.